NO982906L - Heterosyklylkondenserte benzoylguanidiner, deres fremstilling og anvendelse som inhibitorer for den cellulµre Na+/H+-antiporter - Google Patents

Heterosyklylkondenserte benzoylguanidiner, deres fremstilling og anvendelse som inhibitorer for den cellulµre Na+/H+-antiporter

Info

Publication number
NO982906L
NO982906L NO982906A NO982906A NO982906L NO 982906 L NO982906 L NO 982906L NO 982906 A NO982906 A NO 982906A NO 982906 A NO982906 A NO 982906A NO 982906 L NO982906 L NO 982906L
Authority
NO
Norway
Prior art keywords
stands
antiporter
inhibitors
cellular
nha
Prior art date
Application number
NO982906A
Other languages
English (en)
Norwegian (no)
Other versions
NO982906D0 (no
Inventor
Manfred Baumgarth
Rolf Gericke
Klaus-Otto Minck
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO982906D0 publication Critical patent/NO982906D0/no
Publication of NO982906L publication Critical patent/NO982906L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/66Nitrogen atoms not forming part of a nitro radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
NO982906A 1995-12-23 1998-06-22 Heterosyklylkondenserte benzoylguanidiner, deres fremstilling og anvendelse som inhibitorer for den cellulµre Na+/H+-antiporter NO982906L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19548708A DE19548708A1 (de) 1995-12-23 1995-12-23 Cyclische Sulfone
PCT/EP1996/005645 WO1997023476A1 (de) 1995-12-23 1996-12-16 HETEROCYCLYLKONDENSIERTE BENZOYLGUANIDINE, DEREN HERSTELLUNG UND DEREN VERWENDUNG ALS INHIBITOREN DES ZELLULÄREN Na+/H+-ANTIPORTERS

Publications (2)

Publication Number Publication Date
NO982906D0 NO982906D0 (no) 1998-06-22
NO982906L true NO982906L (no) 1998-06-22

Family

ID=7781400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO982906A NO982906L (no) 1995-12-23 1998-06-22 Heterosyklylkondenserte benzoylguanidiner, deres fremstilling og anvendelse som inhibitorer for den cellulµre Na+/H+-antiporter

Country Status (18)

Country Link
US (1) US6028069A (de)
EP (1) EP0873335A1 (de)
JP (1) JP2000502663A (de)
KR (1) KR19990076675A (de)
AR (1) AR004402A1 (de)
AU (1) AU710048B2 (de)
BR (1) BR9612200A (de)
CA (1) CA2241143A1 (de)
CZ (1) CZ199798A3 (de)
DE (1) DE19548708A1 (de)
HU (1) HUP9802920A3 (de)
NO (1) NO982906L (de)
PL (1) PL327186A1 (de)
RU (1) RU2161616C2 (de)
SK (1) SK81598A3 (de)
TW (1) TW381091B (de)
WO (1) WO1997023476A1 (de)
ZA (1) ZA9610724B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4328352A1 (de) * 1993-08-24 1995-03-02 Hoechst Ag Substituierte N,N'-Di-benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
WO1998055475A1 (en) * 1997-06-02 1998-12-10 Fujisawa Pharmaceutical Co., Ltd. Guanidine deriviatives as inhibitors of na+/h+ exchange in cells
US6730697B2 (en) * 2002-02-07 2004-05-04 Aventis Pharma Deutschland Gmbh Dihydrothiaphenanthrenecarbonylguanidines: composition, process of making, and use as medicament or diagnostic aid
TW200614995A (en) * 2004-11-10 2006-05-16 Nicholas Piramal India Ltd Tricyclic guanidine derivatives as sodium-proton exchange inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0589336T3 (da) * 1992-09-22 1997-06-16 Hoechst Ag Benzylguanidiner, fremgangsmåde til deres fremstilling samt deres anvendelse som antiarytmetika
ES2152938T3 (es) * 1992-09-28 2001-02-16 Hoechst Ag 1(2h)-isoquinolinas sustituidas antiarritmicas y cardioprotectoras, procedimiento para su produccion, medicamento que las contiene y su uso para la produccion de un medicamento para combatir fallos cardiacos.
US5514801A (en) * 1992-12-29 1996-05-07 Monsanto Company Cyclic sulfone containing retroviral protease inhibitors
CA2121391A1 (en) * 1993-04-28 1994-10-29 Atsuyuki Kojima Indoloylguanidine derivatives
DE4317076A1 (de) * 1993-05-21 1994-11-24 Bayer Ag Benzthiophencarbonsäureamid-S-oxide
US5607898A (en) * 1993-08-02 1997-03-04 Idemitsu Kosan Company, Ltd. Pyrazole derivatives
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
US5627194A (en) * 1993-11-17 1997-05-06 Allelix Biopharmaceuticals Inc. Anti-viral guanidino-substituted compounds
DE4344550A1 (de) * 1993-12-24 1995-06-29 Hoechst Ag Substituierte 1-Oxo-1,2-dihydro-isochinolinoyl- und 1,1-Dioxo-2H-1,2-benzothiazinoylguanidine, Verfahrenzu ihrer Herstellung, ihre Verwendung als Medikamentt oder Diagnostikum sowie sie enthaltendes Medikamen
DE4412334A1 (de) * 1994-04-11 1995-10-19 Hoechst Ag Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
AU683552B2 (en) * 1994-04-11 1997-11-13 Chugai Seiyaku Kabushiki Kaisha 4,6-DI-t-butyl-2,3-dihydrobenzothiophene derivative
US5863936A (en) * 1995-04-18 1999-01-26 Geron Corporation Telomerase inhibitors
US5821250A (en) * 1996-02-01 1998-10-13 The Procter & Gamble Company Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
FR2762598A1 (fr) * 1997-04-25 1998-10-30 Adir Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent

Also Published As

Publication number Publication date
TW381091B (en) 2000-02-01
KR19990076675A (ko) 1999-10-15
NO982906D0 (no) 1998-06-22
HUP9802920A2 (hu) 2000-05-28
CA2241143A1 (en) 1997-07-03
SK81598A3 (en) 1999-01-11
JP2000502663A (ja) 2000-03-07
AU1196097A (en) 1997-07-17
US6028069A (en) 2000-02-22
BR9612200A (pt) 1999-07-13
ZA9610724B (en) 1997-06-26
WO1997023476A1 (de) 1997-07-03
DE19548708A1 (de) 1997-06-26
CZ199798A3 (cs) 1998-10-14
PL327186A1 (en) 1998-11-23
RU2161616C2 (ru) 2001-01-10
HUP9802920A3 (en) 2000-12-28
AR004402A1 (es) 1998-11-04
MX9804972A (es) 1998-09-30
AU710048B2 (en) 1999-09-09
EP0873335A1 (de) 1998-10-28

Similar Documents

Publication Publication Date Title
DE69702605T2 (de) Fotoerzeugung von Aminen aus alpha-Aminoacetophenonen
NO20053246L (no) Kondensert 1,3-dihydroimidazol-ringforbindelse.
CY1113782T1 (el) Παραγωγα 11-υδροξυ-5η-πυρρολο[2,1-c][1,4]βενζοδιαζεπιν-5-ονης ως ενδιαμεσα κλειδια για την παρασκευη c2 υποκατεστημενων πυρρολοβενζοδιαζεπινων
NO20055226L (no) Fremgangsmate for fremstilling av N-substituerte 2-cyanopyrrolidoner
BRPI0211844B8 (pt) composto de ácido fenóxi-acético ou um de seus sais farmaceuticamente aceitáveis, e, composição farmacêutica
CA2324418A1 (en) Novel opiate compounds, methods of making and methods of use
NO950813L (no) Acetamider
NO982906L (no) Heterosyklylkondenserte benzoylguanidiner, deres fremstilling og anvendelse som inhibitorer for den cellulµre Na+/H+-antiporter
ATE273294T1 (de) 4-aminobenzopyranderivate
EP1375496A4 (de) N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält
NO20002490L (no) FremgangsmÕte for fremstilling av 1,4-dihydropyridiner og forbindelser anvendt ved denne fremgangsmÕten
PT1225174E (pt) Cristais de mirtazapina anidros e processo para a sua producao
BR0207830A (pt) Compostos de carbamato para uso em prevenir ou tratar distúrbios de ansiedade
NO20073330L (no) Sulfanylsubstituerte fenylmetanoner som glycintransportor 1 (glyt-1) inhibitorer for behandling av nevrologiske og nevropsykiatriske forstyrrelser
EA200100825A1 (ru) Новые 1-арил-4-тиотриазины
NO20012965L (no) Sulfonyloksazolaminer som terapeutisk aktive forbindelser
FI894783A (fi) Substituerade aromatiska foereningar med verkan pao det centrala nervsystemet.
EA200200807A1 (ru) Аминокислотные соединения и их применение в качестве ингибиторов nep, ace и ece
NO943961L (no) Sykliske aminderivater
NO961537D0 (no) Salpetersyreestere fra derivater av 2-(2,6-dihalofenylamino)-fenylacetoksyeddiksyre, og deres fremstillingsprosedyrer
BR0213176A (pt) Derivados microbiocidas de n-fenil-n-[4-(4-piridil)-2-pirimidin-2-il]amina
NO20085155L (no) Substituerte fenylmetanon-derivativer
TR200002485T2 (tr) N-Sülfonil ve N-Sülfinil Fenilglisinamid
ATE366804T1 (de) Verwendung von modifiziertem lysozyme c in der herstellung von pharmazeutika zur krankheitsbehandlung
EA200000116A1 (ru) Противогрибковые соединения на основе 2,4,4-тризамещенных-1,3-диоксоланов

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application